Which combination with sumatriptan can lead to serotonin syndrome?

Which combination with sumatriptan can lead to serotonin syndrome?

• A. Sumatriptan with Sertraline
• B. Sumatriptan with Fluoxetine
• C. Sumatriptan with Citalopram
• D. Sumatriptan with Celexa

Answer: (D)

Combining a triptan with a serotonergic antidepressant raises the risk of serotonin syndrome. Sumatriptan activates 5-HT1B/1D receptors to relieve migraine, but an SSRI antidepressant increases serotonin levels by blocking reuptake. The combination can produce excessive serotonergic activity in the CNS and periphery, tipping into serotonin syndrome. Any SSRI can contribute, including citalopram (Celexa), sertraline, or fluoxetine. Celexa is the brand name for citalopram, so this pairing is a representative example of the risk. Serotonin syndrome presents with a cluster of symptoms: changes in mental status (agitation, confusion), autonomic instability (tachycardia, hypertension, fever), and neuromuscular abnormalities (hyperreflexia, clonus, tremor). If suspected, discontinue the offending agents and provide supportive care; benzodiazepines can help with agitation, and cyproheptadine may be used if needed. In severe cases, admit for closer monitoring or ICU care. If a patient requires acute migraine treatment while also on an SSRI, consider alternative non-serotonergic options (such as gepants or ditans) and review all serotonergic medications to minimize the risk.

Combining a triptan with a serotonergic antidepressant raises the risk of serotonin syndrome. Sumatriptan activates 5-HT1B/1D receptors to relieve migraine, but an SSRI antidepressant increases serotonin levels by blocking reuptake. The combination can produce excessive serotonergic activity in the CNS and periphery, tipping into serotonin syndrome.

Any SSRI can contribute, including citalopram (Celexa), sertraline, or fluoxetine. Celexa is the brand name for citalopram, so this pairing is a representative example of the risk.

Serotonin syndrome presents with a cluster of symptoms: changes in mental status (agitation, confusion), autonomic instability (tachycardia, hypertension, fever), and neuromuscular abnormalities (hyperreflexia, clonus, tremor). If suspected, discontinue the offending agents and provide supportive care; benzodiazepines can help with agitation, and cyproheptadine may be used if needed. In severe cases, admit for closer monitoring or ICU care.

If a patient requires acute migraine treatment while also on an SSRI, consider alternative non-serotonergic options (such as gepants or ditans) and review all serotonergic medications to minimize the risk.